National Tuberculosis and Leprosy Conrol Programme
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...act that the genetic sequence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had been shared worldwide. It was noted that in one country SARS-CoV-2 had been reconstructed in a laboratory from the viral genome sequence before the first case of COVID-19 had been reported, highlighting the benefits of synthetic biology technologies for accelerated development of diagnostics as well as the oft-described potential risks. Lessons learned about clinical care during the COVID-19 pandemic were also discussed.
more
Technical specifications series for submission to WHO prequalification: diagnostic assessment;TSS-3
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. If not diagnosed at early stages, patients with CBM... require long term therapy with systemic antifungals, sometimes associated with physical methods. Unlike other neglected endemic mycoses, comparative clinical trials have not been performed for this disease. Nowadays, therapy is based on a few open trials and on expert opinion. Itraconazole either as monotherapy or associated with other drugs, or with physical methods, is widely used. Recently, photodynamic therapy has been successfully employed in combination with antifungals in patients presenting with CBM. In the present revision the most used therapeutic options against CBM are reviewed as well as the several factors that may have impact on the patient's outcome.
more
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
A manual for programme managers.
Fort de cela, le Burkina Faso a élaboré ce document de stratégie nationale de promotion de la santé (SNPS) pour contribuer à relever les
défis en matière de développement. Son élaboration a suivi un processus participatif, en s'inspirant du guide méthodologique d’élaboration
des polit...iques sectorielles du Burkina Faso[2]. Ils’articule autour des principaux points suivants :
- la mission du secteur de la santé et rappel de la politique nationale de santé ;
- l’analyse de la situation de la promotion de la santé ;
- la vision, les fondements, et les principes directeurs ;
- les objectifs globaux et les orientations stratégiques ;
- les programmes;
- le financement de la stratégie nationale de promotion de la santé ;
- les mécanismes de mise en œuvre, de suivi et d’évaluation.
more
Regional Tuberculosis Program, Pan American Health Organization (PAHO/WHO)
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme planning and prioritization – user guide, published by the World Health Organization (WHO)... in 2019. The compendium is intended to support implementation of the people-centred framework user guide. It can also be used independently to inform decisions taken by national tuberculosis (TB) programmes about the implementation of the tools included in this document.
more